Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.74% | $1.70M | €414.15B | 52.06% | 76 Outperform | |
| HSBC Holdings | 2.18% | $1.35M | £208.34B | 50.80% | 80 Outperform | |
| Roche Holding AG | 1.84% | $1.14M | CHF275.00B | 44.94% | 73 Outperform | |
| Siemens | 1.67% | $1.04M | €202.13B | 31.05% | 74 Outperform | |
| British American Tobacco | 1.54% | $952.80K | £92.06B | 45.96% | 71 Outperform | |
| AstraZeneca | 1.33% | $822.28K | £222.43B | 34.73% | 80 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 1.32% | $818.75K | €119.64B | 107.84% | 76 Outperform | |
| Allianz | 1.31% | $810.48K | €143.49B | 27.01% | 67 Neutral | |
| Shell (UK) | 1.27% | $789.12K | £155.59B | 2.14% | 73 Outperform | |
| Novartis AG | 1.27% | $784.90K | CHF220.89B | 28.13% | 80 Outperform |